Clinical Trial Update: Allo HSCT Using RIC and PTCy for Hematological Diseases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and post-transplant cyclophosphamide a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Burkitt Lymphoma
• Chronic Lymphocytic Leukemia
• Chronic Myeloid Leukemia
• Follicular Lymphoma
• Myelodysplastic Syndromes
• Small Lymphocytic Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia | Phase 2 | Status: RECRUITING